---
title: "PACB SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Pacific Biosciences (PACB), with links to the SEC filings."
url: "https://tradytics.com/research/PACB/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=PACB&v=stock-11994873"
---

# PACB financial statements and SEC filings

## PACB annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $160.00M | -$553.86M | -$546.38M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/0001299130-26-000034-index.htm) |
| 2024-12-31 | $154.01M | -$474.31M | -$309.85M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/0001299130-26-000034-index.htm) |
| 2023-12-31 | $200.52M | -$334.47M | -$306.74M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/0001299130-26-000034-index.htm) |
| 2022-12-31 | $128.30M | -$307.20M | -$314.25M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913025000061/0001299130-25-000061-index.htm) |
| 2021-12-31 | $130.51M | -$210.44M | -$181.22M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913024000054/0001299130-24-000054-index.htm) |
| 2020-12-31 | $78.89M | -$104.39M | $29.40M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913023000032/0001299130-23-000032-index.htm) |

## PACB annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $784.08M | $778.73M | $5.35M | [10-Q](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000138/0001299130-26-000138-index.htm) |
| 2024-12-31 | $1.26B | $753.85M | $506.59M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/0001299130-26-000034-index.htm) |
| 2023-12-31 | $1.75B | $1.04B | $701.30M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913025000061/0001299130-25-000061-index.htm) |
| 2022-12-31 | $1.77B | $1.20B | $562.90M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913024000054/0001299130-24-000054-index.htm) |
| 2021-12-31 | $2.01B | $1.22B | $790.99M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913023000032/0001299130-23-000032-index.htm) |
| 2020-12-31 | $413.98M | $78.49M | $335.49M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913022000030/0001299130-22-000030-index.htm) |

## PACB annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$111.21M | -$2.71M | $3.43M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/0001299130-26-000034-index.htm) |
| 2024-12-31 | -$206.06M | -$6.19M | -$42.99M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/0001299130-26-000034-index.htm) |
| 2023-12-31 | -$259.17M | -$8.84M | $108.89M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000034/0001299130-26-000034-index.htm) |
| 2022-12-31 | -$263.21M | -$16.75M | $9.62M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913025000061/0001299130-25-000061-index.htm) |
| 2021-12-31 | -$111.18M | -$5.93M | $1.17B | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913024000054/0001299130-24-000054-index.htm) |
| 2020-12-31 | $19.50M | -$1.04M | $251.84M | [10-K](https://www.sec.gov/Archives/edgar/data/1299130/000129913023000032/0001299130-23-000032-index.htm) |

- [PACB stock research](https://tradytics.com/research/PACB)
- [PACB financial summary](https://tradytics.com/research/PACB/financials)
- [Read the data without JavaScript](https://tradytics.com/research/PACB/fundamentals?snapshot=1)
